Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Cladribine 5.6 followed by Rituximab 375, Hairy Cell Leukemia, Part A

Protocol-ID: 865 V1.0 (Mini), CLAD5,6 followed by RITU375, HCL, A

Indication(s)

  • Hairy Cell Leukemia; ICD-10 C91.4-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 13.02.2017